Bio-Techne Corp

TECH

Company Profile

  • Business description

    Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

  • Contact

    614 McKinley Place N.E.
    MinneapolisMN55413
    USA

    T: +1 612 379-8854

    https://www.bio-techne.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    3,100

Stocks News & Analysis

stocks

We lift our fair value estimate for this ASX energy play

Strong oil and LNG prices are a major win, though we don’t think they will stay high in the long term.
stocks

Chart of the Week: Headwinds for Aussie banks point to an imminent slowdown

Investor demand is expected to fade and slow credit growth as borrowers face higher costs and reduced tax breaks.
stocks

Hostile takeover on the cards for this ASX income opportunity

IFM lobs reasonable takeover offer.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,915.7016.000.18%
CAC 408,072.1331.96-0.39%
DAX 4023,954.5663.70-0.27%
Dow JONES (US)48,861.81280.12-0.57%
FTSE 10010,213.11119.68-1.16%
HKSE26,111.84432.061.68%
NASDAQ24,673.249.440.04%
Nikkei 22559,917.46619.90-1.02%
NZX 50 Index12,766.573.73-0.03%
S&P 5007,135.952.85-0.04%
S&P/ASX 2008,687.009.400.11%
SSE Composite Index4,107.5128.880.71%

Market Movers